StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

Equities research analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a note issued to investors on Sunday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

TTOO opened at $0.14 on Friday. The business has a fifty day simple moving average of $0.25 and a 200 day simple moving average of $1.08. T2 Biosystems has a 1 year low of $0.06 and a 1 year high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.